Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 20 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Rheumatic Diseases 9627011 Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. diagnostic usage 3
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Rheumatic Diseases 9627011 Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. ongoing research 4
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Rheumatic Diseases 9627011 Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. unassigned 0
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Mucopolysaccharidosis IV 31450640 Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. causal interaction 4
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Mucopolysaccharidosis IV 31450640 Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. diagnostic usage 3
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Mucopolysaccharidosis IV 31450640 Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. therapeutic application 3
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Mucopolysaccharidosis IV 31450640 Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. ongoing research 4
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Arthritis 8609216 Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. therapeutic application 2
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Arthritis 8609216 Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. unassigned 0
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.103Spondylitis 8609216 Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. therapeutic application 2
Results 1 - 10 of 20 > >>